AIP Medical
ActiveFrom the official registers: KBO 32 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
AIP Medical has been active since 1993 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €302,387. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 72% of 9,829 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 30-07-1993 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460and 3 others
- Establishment unit
- 2.063.371.924 4877 Olne, since 06-09-1993
- Financial year end
- 31 December
- Peppol
- Reachable since 15-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €773,060
- ▲ 18.5%
- Turnover
- ≈ €3.9m
- estimated
- Profit
- €302,387
- ▲ 25.3%
- Equity
- €1.1m
- ▲ 7.5%
- Total assets
- €1.6m
- ▲ 20.4%
- Staff
- 4.6 FTE
- ▲ 7.0%
Score breakdownlowers riskSize: total assets €1.6mFounded in 1993Equity €1.1m (66.0% of total assets)Liquidity: current ratio 2.27, cash €252,686Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 72% of them on solvency, 62% on liquidity, 86% on profitability and 60% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 51 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Higher net result than 88% of companies in wholesale tradesector median €26,864 · 9,808 companies €302,387 View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2025: €302,387 8 years View
- Positive: Result rose in 2025from €241,361 to €302,387 ▲ 25.3% View
Comparable companies
These companies have the same main activity as AIP Medical: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.3m and €2.2m, founded between 1991 and 1996.
| Company | Total assets | Gross margin |
|---|---|---|
| AIP Medical Olne | €1.6m | €0.8m |
| BELDIMED Dison | €2.2m | €0.8m |
| MD MEDICAL Namur | €1.5m | €0.9m |
| YVSOLAB Turnhout | €2.0m | €0.8m |
| H.D.P. MEDICAL Waasmunster | €1.3m | €0.8m |
| NUTRIFARMA Heist-op-den-Berg | €1.8m | €0.6m |
| ECOMAR Ath | €1.4m | €0.6m |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 24-06-2026
- Annual accounts 2024filed on 16-07-2025
- Annual accounts 2023filed on 06-05-2024
- Annual accounts 2022filed on 07-06-2023
Acts in the Belgian Official Gazette
- Amendment of the articlesact of 22-10-2025
- Resignations & appointmentsact of 23-05-2025
- Amendment of the articles · Name · Resignations & appointments · Miscellaneousact of 17-11-2023
- Resignations & appointmentsact of 05-09-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about AIP Medical
- What is the company number of AIP Medical?
- The company number of AIP Medical is 0450.686.744. The VAT number is the same number with BE in front: BE 0450.686.744.
- Where is AIP Medical based?
- The registered office is at Rue des Artisans 2, 4877 Olne.Company details
- What does AIP Medical do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of AIP Medical?
- The legal form of AIP Medical is Public limited company (NV).
- When was AIP Medical founded?
- AIP Medical was founded on 30-07-1993.
- Is AIP Medical still active?
- Yes, AIP Medical is an active enterprise in the KBO register.
- How many employees does AIP Medical have?
- AIP Medical had an average of 4.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of AIP Medical?
- The turnover in financial year 2025 is ≈ €3.9m. This figure is estimated from the gross margin of €773,060 and 37 comparable companies (NACE 464). It probably lies between €2.9m and €6.0m.
- Is AIP Medical profitable?
- In financial year 2025, AIP Medical made a profit of €302,387.
- Where can I find the annual accounts of AIP Medical?
- AIP Medical filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of AIP Medical due?
- AIP Medical must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.